Davidson Kempner Capital Management’s China Biologic Products Holdings, Inc. CBPO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-251,600
| Closed | -$29.8M | – | 764 |
|
|
2021
Q1 | $29.8M | Buy |
+251,600
| New | +$29.8M | 0.3% | 69 |
|
|
2018
Q4 | – | Sell |
-116,400
| Closed | -$9.31M | – | 233 |
|
|
2018
Q3 | $9.31M | Buy |
+116,400
| New | +$10.8M | 0.1% | 118 |
|
|
2017
Q3 | – | Sell |
-110,000
| Closed | -$12.4M | – | 242 |
|
|
2017
Q2 | $12.4M | Sell |
110,000
-75,000
| -41% | -$8.38M | 0.17% | 96 |
|
|
2017
Q1 | $18.5M | Sell |
185,000
-85,140
| -32% | -$9.1M | 0.21% | 67 |
|
|
2016
Q4 | $29M | Hold |
270,140
| – | – | 0.59% | 38 |
|
|
2016
Q3 | $33.6M | Buy |
270,140
+16,000
| +6% | +$1.89M | 0.83% | 25 |
|
|
2016
Q2 | $27M | Buy |
254,140
+14,300
| +6% | +$1.66M | 0.63% | 36 |
|
|
2016
Q1 | $27.4M | Buy |
239,840
+25,000
| +12% | +$2.93M | 0.58% | 40 |
|
|
2015
Q4 | $30.6M | Sell |
214,840
-2,641
| -1% | -$305K | 0.55% | 38 |
|
|
2015
Q3 | $19.6M | Buy |
217,481
+18,615
| +9% | +$1.96M | 0.35% | 64 |
|
|
2015
Q2 | $22.9M | Buy |
198,866
+92,000
| +86% | +$9.67M | 0.37% | 52 |
|
|
2015
Q1 | $10.2M | Hold |
106,866
| – | – | 0.22% | 88 |
|
|
2014
Q4 | $7.13M | Buy |
106,866
+12,821
| +14% | +$795K | 0.13% | 102 |
|
|
2014
Q3 | $5.06M | Hold |
94,045
| – | – | 0.12% | 132 |
|
|
2014
Q2 | $4.18M | Buy |
+94,045
| New | +$3.84M | 0.12% | 108 |
|
Davidson Kempner Capital Management's CBPO Position: Q2 2021 in Review
Davidson Kempner Capital Management sold out of China Biologic Products Holdings, Inc. (CBPO) in Q2 2021, closing a stake of 251,600 shares — an estimated $29.8M sold.
Davidson Kempner Capital Management first reported a position in CBPO in Q2 2014 and held it in 15 quarters. The position peaked at $33.6M in Q3 2016. 0 funds tracked by Wall St. Rank hold CBPO as of Q2 2021.
- Davidson Kempner Capital Management reported no remaining China Biologic Products Holdings, Inc. position as of Q2 2021 after selling out during the quarter.
- Davidson Kempner Capital Management sold 251,600 China Biologic Products Holdings, Inc. shares in Q2 2021, an estimated $29.8M.
- Davidson Kempner Capital Management first reported a position in China Biologic Products Holdings, Inc. in Q2 2014 and held it in 15 quarters.
- Davidson Kempner Capital Management's China Biologic Products Holdings, Inc. position peaked at $33.6M in Q3 2016.
- 0 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q2 2021.
Based on Davidson Kempner Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.